Systematic Review: Allogenic Use of Stromal Vascular Fraction (SVF) and Decellularized Extracellular Matrices (ECM) as Advanced Therapy Medicinal Products (ATMP) in Tissue Regeneration.

Int J Mol Sci · 2020 · PMC7404290 · PMID 32679697

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The IL-6 levels at day 5 showed a trend towards lower levels as compared with day 0, concluding that the administration of allogenic AD-MSCs appears to be safe and feasible in the treatment of ARDS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.